In summary, we have demonstrated that sinefungin, an inhibitor of SET7/9, attenuates not only MGO-induced peritoneal fibrosis in mice but also TGF-β1-induced fibrotic changes in HPMCs by reducing H3K4me1 levels. This evidence concerns the gene SETD7 and Peritoneal Fibrosis.